Search

everythinglearnresearchcommunity

for

Search:↓

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Finasteride doesn't affect ovulation in normal women.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.